Balstilimab Antibody
Balstilimab (AGEN2034) is a fully human IgG4 monoclonal antibody targeting the PD-1 immune checkpoint. It is utilized in research for investigating cancer immunotherapy, with studies demonstrating its activity in both in vitro assays and in vivo tumor models.
Product Specifications
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
8.54 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HY-145383-02 10 mg
Biotin-PEG4-dialkoxydiphenylsilane-picolyl azide
Sign In for Pricing
View Details HY-145383-03 25 mg
Biotin-PEG4-dialkoxydiphenylsilane-picolyl azide
Sign In for Pricing
View Details HY-145383-04 50 mg
Biotin-PEG4-dialkoxydiphenylsilane-picolyl azide
Sign In for Pricing
View Details K4000002 1.0 µg DNA
Sema6b sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
bsm-61741R-PE-Cy5.5 100 µL
Endo G Recombinant Antibody, PE-Cy5.5 Conjugated
Sign In for Pricing
View Details